@endpts.com
We're where the business of medicine gets answers. An independent news media organization covering biotech, pharma, science, policy, finance, venture capital and markets, and how they drive the life sciences industry. Read us at www.endpts.com.
@profgalloway.com
Professor of Marketing at NYU Stern School of Business, serial entrepreneur, and host of the Prof G and Pivot Podcasts.
@drannecarpenter.bsky.social
Dedicated to drug discovery, enthralled by science. 5 kids. She. SAB Recursion. Founder SyzOnc. Lab at Broad Institute. Opinions my own.
@alexharding.bsky.social
mystery vocation (part time) opinions of unknown origin gin > computer | food alexharding.ooo https://www.instagram.com/wash_your_manipulators
@peterkolchinsky.bsky.social
Biotech investor. Virologist. Author: The Great American Drug Deal. Founder: No Patient Left Behind. Healthcare reform advocate. Daughter says I’m cool 75% of the time; son says 100%.
@pjobphd.bsky.social
Biomarker Nerd, Bot blocker Limiting Science posts for now because CECOT is a Death Camp
@scottgottliebmd.bsky.social
Senior Fellow at the American Enterprise Institute. Partner, New Enterprise Associates. Contributor CNBC. 23rd Commissioner of the U.S. FDA. Public boards: Pfizer, Illumina, TempusAI.
@jmaraganore.bsky.social
Founding CEO of Alnylam Pharmaceuticals. RNAi therapeutics pioneer. CEO and Principal of JMM Innovations, LLC. Committed to advancing biomedical innovation to patients.
@erictopol.bsky.social
physician-scientist, author, editor https://www.scripps.edu/faculty/topol/ Ground Truths https://erictopol.substack.com SUPER AGERS https://www.simonandschuster.com/books/Super-Agers/Eric-Topol/9781668067666
@arsalan.endpoints.news
Founder/CEO of Endpoints News (acquired by the Financial Times). Lawrence, Kansas-based aviator. Sharing occasional biopharma news biz takes and cockpit views. @AKAarsalan on twitter
@massbio.bsky.social
MassBio is committed to advancing Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives.
@wyssinstitute.bsky.social
The Wyss Institute seeks to transform engineering, medicine and the environment by creating new materials and devices using Nature’s design principles.
@reuters.com
@sciencenews.bsky.social
We report on the latest news in all fields of science. See also @snexplores.bsky.social
@gilman.bsky.social
Scientist, entrepreneur, ex-biopharm exec, former FM radio jock, lifelong hockey fan, aspiring guitar player and mixologist, #immigrant, #BioSky. CEO, Arrakis Therapeutics and a variety of other things. https://www.michaelgilman.net/disclosures/
@currentbiology.bsky.social
Scientific journal publishing research, overview, commentary across all of biology. All of it! https://www.cell.com/current-biology/home Part of CellPress
@jordixiol.bsky.social
Science, history, and drug development | https://vineyardbooks.substack.com/
@lifescivc.bsky.social
Early stage biotech VC. Recovering scientist. Opinions expressed are solely my own and do not express the views or opinions of Atlas Venture.
@drsam.bsky.social
Pediatric oncologist. Cancer drug developer. Dad joke aficionado. Moth GrandSLAM winner. Climber of mountains. Raconteur. Baker. Orcasonian. Entrepreneur-in-Residence @ GV. I'm also at https://substack.com/@drsamblackman
@artkrieg.bsky.social
Love trail running, hiking, Toll-Like receptors 7/8/9, P1 pDC. Founder/CEO of Zola Therapeutics
@drnadolsky.bsky.social
Obesity and lipid specialist physician. Founder of Vineyard. Co-host of Docs Who Lift Podcast
@biochemjessie.bsky.social
Biotech, adventures, people who do good, Boston local stuff (she/her)
@bsky.app
official Bluesky account (check username👆) Bugs, feature requests, feedback: [email protected]